Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results

BACKGROUND: Open-label 15-month follow-up of the double-blind, placebo-controlled Glatiramer Acetate clinical Trial to assess Equivalence with Copaxone(®) (GATE) trial. OBJECTIVE: To evaluate efficacy, safety, and tolerability of prolonged generic glatiramer acetate (GTR) treatment and to evaluate e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mult Scler
Päätekijät: Selmaj, Krzysztof, Barkhof, Frederik, Belova, Anna N, Wolf, Christian, van den Tweel, Evelyn RW, Oberyé, Janine JL, Mulder, Roel, Egging, David F, Koper, Norbert P, Cohen, Jeffrey A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2017
Aiheet:
Original Research Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700775/
https://ncbi.nlm.nih.gov/pubmed/28090798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458516688956
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia